Phytanic acids is a retinoid X receptor ligand

European Journal of Biochemistry

Volumn 236, Issue 1, 1996, Pages 328-333

  Lemotte, P K ^a   Keidel, S ^a   Apfel, C M ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Fatty acids; Phytanic acid; Refsum's disease; Retinoic acid; Retinoid X receptor

Indexed keywords

PHYTANIC ACID; RETINOIC ACID; RETINOID X RECEPTOR; LIGAND; RECOMBINANT PROTEIN; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FATTY ACID METABOLISM; GENE EXPRESSION REGULATION; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN STRUCTURE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; ESCHERICHIA COLI; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REFSUM DISEASE; TRANSACTIVATION;

BASE SEQUENCE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PHYTANIC ACID; RECEPTORS, RETINOIC ACID; RECOMBINANT PROTEINS; REFSUM DISEASE; RETINOID X RECEPTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRETINOIN;

EID: 0029664544     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1996.00328.x     Document Type: Article

References (33)

1. 1 Steinberg, D., Avignan, T. & Mize, C. (1965) Conversion of U‐C 14 ‐phytol to phytanic acid and its oxidation in heredopathia atactica polyneuritiformis, Biochem. Biophys. Res. Commun. 19, 783–789.
2. 2 Bioukar, E. B. & Deschatrette, J. (1993) Update on genetic and molecular investigations of diseases with general impairment of peroxisomal functions, Biochimie 75, 303–308.
3. 3 Refsum, S. (1946) Heredopathia atactica polyneuritiformis: familial syndrome not hitherto described: contribution to clinical study of hereditary diseases of nervous system, Acta Psychiat. Scand. Suppl. 38, 1–303.
4. 4 Molzer, B., Stocker, S. & Bernheimer, H. (1992) Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers, Klin. Wochenschr. 104, 665–670.
5. 5 Avignan, J. (1966) The presence of phytanic acid in normal and animal plasma, Biochim. Biophys. Acta 166, 391–394.
6. 6 Reynolds, D. J., Marks, R., Davies, M. & Dykes, P. (1978) The fatty acid composition of skin and plasma lipids in Refsum's disease. Clin. Chim. Acta. 90, 171–177.
7. 7 Mamendier, C. L., Jonniaux, G., Voet, W. & Van den Bergen, C. J. (1974) Fatty acid composition of tissues in Refsum's disease (herodopathia alactica polyneuritiformis). Estimation of total phytanic acid accumulation, Biomedicine 20, 398–407.
8. 8 Molzer, B., Kainz‐Korschinsky, M., Sundt‐Heller, R. & Bernheirner, H. (1989) Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders, J. Clin. Chem. Chi. Biochem. 27, 309–314.
9. 9 Molzer, B., Stöckler, S. & Bernheimer, H. (1992) Peroxisomal neurologic diseases and Refsum's disease: very long chain fatty acids and phytanic acid as diagnostic markers, Wien Klin. Wochenschr. 104, 665–670.
10. 10 Klenk, E. & Kahlke, W. (1963) Über das Vorkommern der 3.7.11.15–Tetramethyl‐hexadecan‐säure (Phytansäure) in den Cholesterinestern und anderen Lipoidfraktionen der Organe bei einem Krankheitsfall unbekannter Genese (Refsum‐Syndrom), Z. Physiol. Chem. 333, 133–139.
11. 11 Hansen, R. P. (1965) 3,7,11,15–Teramethylhexadecanoic acid. Its occurence in the tissues of humans afflicted with Refsum's syn‐drome, Biochim. Biophys. Acta 106, 304–310.
12. 12 Issemann, I. & Green, S. (1992) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators, Nature 347, 645–650.
13. 13 Göttlicher, M., Widmark, E., Li, Q. & Gustafsson, J. A. (1992) Fatty acids activate a chimera of the clofibric acid‐activated receptor and the glucocorticoid receptor, Proc. Natl Acad. Sci. USA 89, 4653–4657.
14. 14 Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A. & Evans, R. M. (1992) Convergence of 9‐ cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors, Nature 358, 771–774.
15. 15 Mangelsdorf, D. J., Umesono, K. & Evans, R. M. (1994) in The retinoids: Biology, chemistry and medicine ( Sporn, M. B., Robertes, A. B. & Goodman, D. S., eds) pp. 319–349. Raven Press, New York.
16. 16 Levin, A. A., Sturzenbecker, L. J., Kazmer, S., Bosakowski, T., Huselton, C., Allenby, G., Speck, J., Kratzeisen, C., Rosenberger, M., Lovey, A. & Grippo, J. F. (1992) 9‐ Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα, Nature 355, 359–361.
17. 17 Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichcle, G., Evans, R. M. & Thaller, C. (1992) 9‐ Cis retinoic acid is a high affinity ligand for the retinoid‐X receptor, Cell 68, 397–406.
18. 18 Hall, C. V., Jacob, P. E., Ringold, G. M. & Lee, F. (1983) Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells, J. Mol. Appl. Genet. 2, 101–109.
19. 19 Petkovich, M., Brand, N. J., Krust, A. & Chambon, P. (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors, Nature 330, 444–450.
20. 20 Thé, H. de, Marchio, A., Tiollais, P. & Dejean, A. (1987) A novel steroid thyroid hormone receptor‐related gene inappropriately expressed in human hepatocellular carcinoma, Nature 330, 617–670.
21. 21 Berger, J., Hauber, J., Hauber, R., Geiger, R. & Cullen, B. R. (1988) Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells, Gene 66, 1–10.
22. 22 Apfel, C., Bauer, F., Crettaz, M., Forni, L., Kamber, M., Kaufmann, F., LeMotte, P., Pirson, W. & Klaus, M. (1992) A retinoic acid receptor‐α antagonist selectivly counteracts retinoic acid effects, Proc. Natl Acad. Sci. USA 89, 7129–7133.
23. 23 Bond, B. J. & Davidson, N. (1986) The Drosophila melanogaster actin 5C gene uses two transcription initiations sites and three polyadenylation sites to express multiple mRNA species, Mol. Cell. Biol. 6, 2080–2088.
24. 24 Mangelsdorf, D. J., Umesono, K., Kliewer, S. A., Borgmeyer, U., Ong, E. S. & Evans, R. M. (1991) A direct repeat in the cellular retinol‐binding protein type‐II gene confers differential regulation by RXR and RAR, Cell 66, 555–561.
25. 25 Mangelsdorf, D. J., Ong, E. S., Dyck, J. A. & Evans, R. M. (1990) Nuclear receptor that identifies a novel retinoic acid response pathway, Nature 345, 224–229.
26. 26 Stüber, D., Matile, H. & Garotta, G. (1990) in Inmunologic methods, vol. IV ( Lefkovits, J. & Pernis, B., eds) pp. 121–152, Aca‐demic Press, Orlando FL.
27. 27 Crettaz, M., Baron, A., Siegentahler, G. & Hunziker, W. (1990) Ligand specificities of recombinant retinoic acid receptors RAR‐α and RAR‐β, Biochem. J. 272, 391–397.
28. 28 Studier, F. W. & Moffatt, B. A. (1986) Use of bacteriophage T7 RNA polymerase to direct selective high‐level expression of cloned genes, J. Mol. Biol. 189, 113–130.
29. 29 Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989) in Molecular cloning a laboratory manual ( Sambrook, J., Fritsch, E. F. & Maniatis, T., eds) Cold Spring Harbor Laboratory Press, Cold Spring Harbor NY.
30. 30 Keidel, S., LeMotte, P. & Apfel, C. (1994) Different agonist‐induced and antagonist‐induced conformational changes in retinoic acid receptors analyzed by protease mapping, Mol. Cell. Biol. 14, 287–298.
31. 31 Zhang, X. K., Lehmann, J., Hoffmann, B., Dawson, M. I., Cameron, J., Graupner, G., Hermann, T., Tran, P. & Pfahl, M. (1992) Homodimer formation of retinoid X receptor induced by 9‐ cis retinoic acid, Nature 358, 587–591.
32. 32 Eager, N. S. C., Brickell, P. M., Snell, C. & Wood, J. N. (1992) Structural and functional evidence for activation of a chick retinoid‐X receptor by eicosanoids, Proc. R. Soc. Lond. Ser, B. Biol. Sci. 250, 63–69.
33. 33 Steinberg, D. (1989) Refsum disease, in The metabolic basis of inherited disease ( Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle, D., eds) 6th edn, McGraw‐Hill, New York.